BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9797396)

  • 1. Efficacy of different mesalamine-releasing drugs.
    Gross V
    Gastroenterology; 1998 Nov; 115(5):1306-7. PubMed ID: 9797396
    [No Abstract]   [Full Text] [Related]  

  • 2. Will the real 5-aminosalicylic acid please stand up?
    Regueiro MD
    Inflamm Bowel Dis; 1999 May; 5(2):147-8. PubMed ID: 10338387
    [No Abstract]   [Full Text] [Related]  

  • 3. Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?
    Farrell RJ; Peppercorn MA
    Am J Gastroenterol; 2002 Jun; 97(6):1283-5. PubMed ID: 12094839
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
    Hanauer SB
    Am J Gastroenterol; 2003 Mar; 98(3):697-8. PubMed ID: 12650813
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review.
    Kane SV; Bjorkman DJ
    Rev Gastroenterol Disord; 2003; 3(4):210-8. PubMed ID: 14668693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
    Hanauer SB
    Gut; 1999 Apr; 44(4):455. PubMed ID: 10075949
    [No Abstract]   [Full Text] [Related]  

  • 7. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balsalazide disodium.
    Am J Health Syst Pharm; 2002 Jan; 59(1):27. PubMed ID: 11813462
    [No Abstract]   [Full Text] [Related]  

  • 9. Review article: balsalazide therapy in ulcerative colitis.
    Ragunath K; Williams JG
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1549-54. PubMed ID: 11563993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mesalamine wars heat up-enter balsalazide.
    Cohen RD
    Gastroenterology; 2003 Feb; 124(2):574-5. PubMed ID: 12557164
    [No Abstract]   [Full Text] [Related]  

  • 11. Balsalazide.
    Prakash A; Spencer CM
    Drugs; 1998 Jul; 56(1):83-9; discussion 90. PubMed ID: 9664201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.
    Green JR; Lobo AJ; Holdsworth CD; Leicester RJ; Gibson JA; Kerr GD; Hodgson HJ; Parkins KJ; Taylor MD
    Gastroenterology; 1998 Jan; 114(1):15-22. PubMed ID: 9428213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis.
    Hanauer SB
    Am J Gastroenterol; 2003 Jan; 98(1):215-6. PubMed ID: 12526968
    [No Abstract]   [Full Text] [Related]  

  • 15. Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis.
    Muijsers RB; Goa KL
    Drugs; 2002; 62(11):1689-705. PubMed ID: 12109930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE; Kane S
    Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral balsalazide (Colazal) for ulcerative colitis.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of treatment for ulcerative colitis.
    Steinberg H
    JAMA; 1998 Aug; 280(5):422. PubMed ID: 9701075
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ulcerative colitis with balsalazide: response to editorial by Drs. Farrell and Peppercorn and letter to the editor by Dr. Hanauer.
    Johnson LK; Pruitt RE; Green JR
    Am J Gastroenterol; 2003 Jan; 98(1):216-9. PubMed ID: 12526969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.